Results 31 to 40 of about 5,258 (146)

Antibacterial effect of phage cocktails and phage-antibiotic synergy against pathogenic <i>Klebsiella pneumoniae</i>. [PDF]

open access: yesmSystems
ABSTRACT The global rise of antibiotic resistance has renewed interest in phage therapy, as an alternative to antibiotics to eliminate multidrug-resistant (MDR) bacterial pathogens. However, optimizing the broad-spectrum efficacy of phage therapy remains a challenge.
Zhao M   +5 more
europepmc   +4 more sources

Computational Basis for On-Demand Production of Diversified Therapeutic Phage Cocktails. [PDF]

open access: yesmSystems, 2020
The antibiotic resistance crisis has led to renewed interest in phage therapy as an alternative means of treating infection. However, conventional methods for isolating pathogen-specific phage are slow, labor-intensive, and frequently unsuccessful. We have demonstrated that computationally identified prophages carried by near-neighbor bacteria can ...
Mageeney CM   +8 more
europepmc   +6 more sources

Evaluating the effectiveness of a non-locally developed commercial phage cocktail on Kenyan Pseudomonas aeruginosa isolates

open access: yesJournal of Microbiology and Infectious Diseases, 2023
Objectives: The use of bacteriophages (phages) as an alternative treatment for multidrug-resistant bacteria has recently gained popularity. Phage cocktails have been proposed for broad-spectrum therapeutic effects against such resistant bacteria ...
Ivy Jepkurui Mutai   +5 more
doaj   +1 more source

Multireceptor phage cocktail against Salmonella enterica to circumvent phage resistance [PDF]

open access: yesmicroLife
Abstract Non-Typhoidal Salmonella (NTS) is one of the most common food-borne pathogens worldwide, with poultry products being the major vehicle for pathogenesis in humans. The use of bacteriophage (phage) cocktails has recently emerged as a novel approach to enhancing food safety.
Carlos E Martinez-Soto   +5 more
openaire   +3 more sources

Model-informed development of bacteriophage therapy: bridging in vitro and in vivo efficacy against multidrug-resistant Pseudomonas aeruginosa

open access: yesmSystems
Bacteriophages are emerging as promising alternatives to antibiotics for multidrug-resistant (MDR) infections. However, their unique pharmacokinetic and pharmacodynamic (PKPD) properties arising from host-dependent amplification present challenges for ...
Jun Seok Cha   +9 more
doaj   +1 more source

PHAGE COCKTAILS AGAINST HIGHLY MULTI-DRUG RESISTANT ACINETOBACTER BAUMANII

open access: yesThe Iraqi Journal of Medical Sciences, 2018
Background:Phage therapy is a potential alternative treatment for infections caused by many bacterial species such as Acinetobacter baumannii (A.
Hayder Jasim, Ahmad Abdul-Ameer
doaj   +1 more source

Isolation and characterization of φkm18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumannii. [PDF]

open access: yesPLoS ONE, 2012
AIMS: To isolate phages against extensively drug resistant Acinetobacter baumannii (XDRAB) and characterize the highest lytic capability phage as a model to evaluate the potential on phage therapy.
Gwan-Han Shen   +7 more
doaj   +1 more source

A Method for Generation Phage Cocktail with Great Therapeutic Potential

open access: yesPLoS ONE, 2012
Bacteriophage could be an alternative to conventional antibiotic therapy against multidrug-resistant bacteria. However, the emergence of resistant variants after phage treatment limited its therapeutic application.In this study, an approach, named "Step-by-Step" (SBS), has been established.
Jingmin Gu   +11 more
openaire   +4 more sources

A blueprint for broadly effective bacteriophage-antibiotic cocktails against bacterial infections

open access: yesNature Communications
Bacteriophage (phage) therapy is a promising therapeutic modality for multidrug-resistant bacterial infections, but its application is mainly limited to personalized therapy due to the narrow host range of individual phages.
Minyoung Kevin Kim   +8 more
doaj   +1 more source

Mesoporous Catalytic‐Adsorptive Nanoregulator Orchestrates Biofilm eDNA/LPS Disassembly and TLR9/TLR4 Immune Reprogramming to Resolve Diabetic Foot Infections

open access: yesAdvanced Science, EarlyView.
Chronic diabetic wounds are hindered by a “dual trap” of biofilm resistance and hyperinflammation. A mesoporous catalytic‐adsorptive nano‐regulator is developed to dismantle this barrier through simultaneous eDNA degradation and LPS sequestration. By silencing TLR4/9‐mediated signaling, the platform clears resilient pathogens and reprograms the immune ...
Junfeng Song   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy